Position in QURE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,717
New position
Shares Held
59
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 31 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $58,541 across 13 Biotechnology names. QURE ranks #8 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $15,588 | |
| 2 | INSM |
INSMED Inc
|
98 | $10,448 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
153 | $8,344 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12 | $5,960 | |
| 5 | ABVX |
Abivax S.A.
|
41 | $5,463 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
50 | $4,078 | |
| 7 | BLTE |
Belite Bio, Inc
|
18 | $2,771 | |
| 8 | QURE |
uniQure N.V.
This page
|
59 | $2,717 |
All Filings in QURE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,717 | 59 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||